Search Results - "Bartkowiak, Detlef"

Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial by Wiegel, Thomas, Bartkowiak, Detlef, Bottke, Dirk, Bronner, Claudia, Steiner, Ursula, Siegmann, Alessandra, Golz, Reinhard, Störkel, Stephan, Willich, Normann, Semjonow, Axel, Stöckle, Michael, Rübe, Christian, Rebmann, Udo, Kälble, Tilman, Feldmann, Horst Jürgen, Wirth, Manfred, Hofmann, Rainer, Engenhart-Cabillic, Rita, Hinke, Axel, Hinkelbein, Wolfgang, Miller, Kurt

“…Abstract Background Local failure after radical prostatectomy (RP) is common in patients with cancer extending beyond the capsule. Three prospectively…”
Get full text

Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa) by Merzenich, Hiltrud, Baaken, Dan, Schmidt, Marcus, Bekes, Inga, Schwentner, Lukas, Janni, Wolfgang, Woeckel, Achim, Bartkowiak, Detlef, Wiegel, Thomas, Blettner, Maria, Wollschläger, Daniel, Schmidberger, Heinz

“…Purpose Radiotherapy (RT) was identified as a risk factor for long-term cardiac effects in breast cancer patients treated until the 1990s. However, modern…”
Get full text

Prostate-Specific Antigen Persistence After Radical Prostatectomy as a Predictive Factor of Clinical Relapse-Free Survival and Overall Survival: 10-Year Data of the ARO 96-02 Trial by Wiegel, Thomas, MD, Bartkowiak, Detlef, PhD, Bottke, Dirk, MD, Thamm, Reinhard, MD, Hinke, Axel, PhD, Stöckle, Michael, MD, Rübe, Christian, MD, Semjonow, Axel, MD, Wirth, Manfred, MD, Störkel, Stephan, MD, Golz, Reinhard, MD, Engenhart-Cabillic, Rita, MD, Hofmann, Rainer, MD, Feldmann, Horst-Jürgen, MD, Kälble, Tilman, MD, Siegmann, Alessandra, MD, Hinkelbein, Wolfgang, MD, Steiner, Ursula, MD, Miller, Kurt, MD

“…Objective The ARO 96-02 trial primarily compared wait-and-see (WS, arm A) with adjuvant radiation therapy (ART, arm B) in prostate cancer patients who achieved…”
Get full text

Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) by Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael

“…Purpose The optimal treatment for patients with low to early-intermediate risk prostate cancer (PCa) remains to be defined. The randomized PREFERE trial…”
Get full text

A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany by Baaken, Dan, Merzenich, Hiltrud, Schmidt, Marcus, Bekes, Inga, Schwentner, Lukas, Janni, Wolfgang, Wöckel, Achim, Mayr, Manfred, Mose, Stephan, Merz, Thomas, Ghilescu, Voica, Renner, Jona, Bartkowiak, Detlef, Wiegel, Thomas, Blettner, Maria, Schmidberger, Heinz, Wollschläger, Daniel

“…Previous studies with the majority of breast cancer (BC) patients treated up to 2000 provided evidence that radiation dose to the heart from radiotherapy (RT)…”
Get full text

Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy by Miksch, Jonathan, Bottke, Dirk, Krohn, Thomas, Thamm, Reinhard, Bartkowiak, Detlef, Solbach, Christoph, Bolenz, Christian, Beer, Meinrad, Wiegel, Thomas, Beer, Ambros J., Prasad, Vikas

“…Purpose 68 Ga-PSMA-11-PET/CT is increasingly used in early-stage biochemical recurrence of prostate cancer to detect potential lesions for an individualized…”
Get full text

Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) by Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael

“…The above mentioned corrections will not change the interpretation or conclusions…”
Get full text

Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact by Stockinger, Marcus, Karle, Heiko, Rennau, Hannes, Sebb, Sabine, Wolf, Ulrich, Remmele, Julia, Bührdel, Sandra, Bartkowiak, Detlef, Blettner, Maria, Schmidberger, Heinz, Wollschläger, Daniel

“…Cardiac effects after breast cancer radiation therapy potentially affect more patients as survival improves. The heart's heterogeneous radiation exposure and…”
Get full text

Salvage radiotherapy after prostatectomy – What is the best time to treat? by Siegmann, Alessandra, Bottke, Dirk, Faehndrich, Julia, Brachert, Maike, Lohm, Gunnar, Miller, Kurt, Bartkowiak, Detlef, Hinkelbein, Wolfgang, Wiegel, Thomas

“…Abstract Purpose Salvage radiotherapy (SRT) is applied routinely in patients with biochemical relapse after radical prostatectomy (RP). However, only ∼30% of…”
Get full text

Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten’s to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) by Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael

Get full text

Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy by Bottke, Dirk, Miksch, Jonathan, Thamm, Reinhard, Krohn, Thomas, Bartkowiak, Detlef, Beer, Meinrad, Bolenz, Christian, Beer, Ambros J., Prasad, Vikas, Wiegel, Thomas

“…Background and Purpose Salvage radiotherapy (SRT) is the main potentially curative treatment option for prostate cancer patients with post-prostatectomy PSA…”
Get full text

Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancer by Bartkowiak, Detlef, Bottke, Dirk, Wiegel, Thomas

“…PURPOSE OF REVIEWAs the appropriate management of patients after prostatectomy is still controversial, the two major approaches, adjuvant radiotherapy (ART)…”
Get full text

The impact of prostate‐specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer by Bartkowiak, Detlef, Siegmann, Alessandra, Böhmer, Dirk, Budach, Volker, Wiegel, Thomas

“…Objective To test whether salvage radiotherapy (SRT) in patients with lymph node negative (N0) prostate cancer is equally effective with persistent…”
Get full text

Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer by Bartkowiak, Detlef, Thamm, Reinhard, Siegmann, Alessandra, Böhmer, Dirk, Budach, Volker, Wiegel, Thomas

“…•Topic: Salvage radiotherapy for post-prostatectomy persistent/recurrent disease.•Problem: Early radiotherapy results in lead-time compared with delayed…”
Get full text

Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival by Bartkowiak, Detlef, Thamm, Reinhard, Bottke, Dirk, Siegmann, Alessandra, Böhmer, Dirk, Budach, Volker, Wiegel, Thomas

“…For patients with recurrent prostate cancer after radical prostatectomy (RP), salvage radiotherapy (SRT) is a second chance of cure. However, depending on risk…”
Get more information

Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer by Bottke, Dirk, Bartkowiak, Detlef, Siegmann, Alessandra, Thamm, Reinhard, Böhmer, Dirk, Budach, Volker, Wiegel, Thomas

“…Background For patients with recurrent prostate cancer after radical prostatectomy (RP), salvage radiotherapy (SRT) offers a second chance of cure. European…”
Get full text

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series by Fossati, Nicola, Karnes, R. Jeffrey, Boorjian, Stephen A, Moschini, Marco, Morlacco, Alessandro, Bossi, Alberto, Seisen, Thomas, Cozzarini, Cesare, Fiorino, Claudio, Chiorda, Barbara Noris, Gandaglia, Giorgio, Dell’Oglio, Paolo, Joniau, Steven, Tosco, Lorenzo, Shariat, Shahrokh, Goldner, Gregor, Hinkelbein, Wolfgang, Bartkowiak, Detlef, Haustermans, Karin, Tombal, Bertrand, Montorsi, Francesco, Van Poppel, Hein, Wiegel, Thomas, Briganti, Alberto

“…Abstract Background Three prospective randomised trials reported discordant findings regarding the impact of adjuvant radiation therapy (aRT) versus…”
Get full text

3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study) by Merzenich, Hiltrud, Bartkowiak, Detlef, Schmidberger, Heinz, Schmidt, Marcus, Schwentner, Lukas, Wiegel, Thomas, Woeckel, Achim, Wollschläger, Daniel, Blettner, Maria

“…Purpose In breast cancer patients treated in the 1970s and 1980s, radiation therapy (RT) for left-sided tumors has been associated with an elevated risk of…”
Get full text

The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival by Bartkowiak, Detlef, Bottke, Dirk, Thamm, Reinhard, Siegmann, Alessandra, Hinkelbein, Wolfgang, Wiegel, Thomas

“…Abstract Background and purpose In a retrospective analysis, we examined factors influencing the outcome of prostate cancer (PCa) patients receiving salvage…”
Get full text

PREFEREnce-based Randomized Evaluation of Treatment Modalities in Low or Early Intermediate-risk Prostate Cancer by Wiegel, Thomas, Stöckle, Michael, Bartkowiak, Detlef

“…Take Home Message The clinical trial PREFERE aims to recruit 7600 patients with “early intermediate” prostate cancer. The goal is to confirm noninferiority of…”
Get full text